The Cannabis Industry Council (CIC) is delighted to announce the shortlisted nominees for the Cannabis Industry Awards 2026, celebrating the individuals whose dedication, expertise and achievements are helping to shape the future of the UK’s cannabis industry. From advancing patient care and scientific research to championing sustainability, advocacy and exceptional customer service, this year’s nominees […]
Read More
With nominations now closed for the Cannabis Industry Awards 2026, we introduce this year’s judging panel and find out what they will be looking for as they assess the individuals driving progress across the UK cannabis sector. Thank you to everyone who submitted a nomination for this year’s Cannabis Industry Awards. Following the close of […]
Read More
The Cannabis Industry Council (CIC) has announced Beyond Awareness: Patient Choice, Safety & Improved Quality of Life, a live educational broadcast bringing together patients, patient organisations, healthcare professionals, researchers, policymakers and industry leaders to explore the realities of navigating chronic conditions and treatment in the UK. Register now! Taking place on Tuesday 20 October 2026 […]
Read More
The UK Food Standards Agency (FSA) has issued a letter to stakeholders to clarify the potential impact of the proposed UK-EU Sanitary and Phytosanitary (SPS) Agreement on novel foods, including CBD products. Following enquiries from retailers about what a future SPS agreement could mean for the CBD market, the FSA has confirmed that its current […]
Read More
The CIC is closely monitoring the anticipated publication of the Advisory Council on the Misuse of Drugs (ACMD) report on medical cannabis, which has been expected to publish this summer and has yet to be released. The CIC made a submission to the call for evidence back in autumn 2025. The report is expected to examine the evidence […]
Read More
The CIC welcomes the appointment of Andy Burnham as Prime Minister and Yvette Cooper as Secretary of State for Health & Social Care. We are optimistic that the new government presents an opportunity for constructive, evidence-led engagement on the future of medical cannabis in the UK. The UK’s medical cannabis sector has matured significantly since […]
Read More
New FOI data has revealed that pharmacist independent prescribers are responsible for the majority of cannabis-based medicinal product (CBPM) prescriptions issued in the UK. The analysis found that pharmacist independent prescribers accounted for 955,471 prescription items, representing 61.9% of the 1.54 million CBPM items prescribed between January 2019 and May 2025. Doctors accounted for 35.8% […]
Read More
The latest Care Quality Commission (CQC) annual update on controlled drugs offers another encouraging snapshot of the continued development of the UK’s medical cannabis sector. Some of key takeaways include: A 2.3x increase in cannabis-based products for medicinal use (CBPMs) prescribed in the year to 31 March 2025, demonstrating continued growth in patient access. 63% […]
Read More
Nominations are now open for the Cannabis Industry Awards 2026, recognising individuals who have made outstanding contributions to the UK’s cannabis sector. The event is kindly presented by Aurora Medicine and MediStack. Hosted by the Cannabis Industry Council, the Cannabis Industry Awards celebrate excellence, leadership and innovation across the UK’s legal cannabis industry. Winners will […]
Read More
The CIC is proud to represent more than 100 member organisations spanning the UK’s cannabis ecosystem, including manufacturers, distributors, clinics, pharmacies, patient organisations, research bodies, professional services, and CBD and industrial hemp businesses. Together, our members account for a significant proportion of prescribing activity, product supply and regulatory engagement across the sector. By bringing industry […]
Read More